In the current COVID-19 pandemic, which has caused many severe death cases for people worldwide since the beginning, changes in TGF-β1 expression at SARS-CoV-2 targeted tissues and its concentration in serum samples have been investigated. This evidence concerns the gene TGFB1 and COVID-19.